These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28368584)

  • 1. Use of Molecular Modeling to Design Selective NTS2 Neurotensin Analogues.
    Fanelli R; Floquet N; Besserer-Offroy É; Delort B; Vivancos M; Longpré JM; Renault P; Martinez J; Sarret P; Cavelier F
    J Med Chem; 2017 Apr; 60(8):3303-3313. PubMed ID: 28368584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotensin Analogues Containing Cyclic Surrogates of Tyrosine at Position 11 Improve NTS2 Selectivity Leading to Analgesia without Hypotension and Hypothermia.
    Eiselt E; Gonzalez S; Martin C; Chartier M; Betti C; Longpré JM; Cavelier F; Tourwé D; Gendron L; Ballet S; Sarret P
    ACS Chem Neurosci; 2019 Nov; 10(11):4535-4544. PubMed ID: 31589400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotensin(8-13) analogs as dual NTS1 and NTS2 receptor ligands with enhanced effects on a mouse model of Parkinson's disease.
    Kühl T; Georgieva MG; Hübner H; Lazarova M; Vogel M; Haas B; Peeva MI; Balacheva AA; Bogdanov IP; Milella L; Ponticelli M; Garev T; Faraone I; Detcheva R; Minchev B; Petkova-Kirova P; Tancheva L; Kalfin R; Atanasov AG; Antonov L; Pajpanova TI; Kirilov K; Gastreich M; Gmeiner P; Imhof D; Tzvetkov NT
    Eur J Med Chem; 2023 Jun; 254():115386. PubMed ID: 37094450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based exploration of an allosteric binding pocket in the NTS1 receptor using bitopic NT(8-13) derivatives and molecular dynamics simulations.
    Kling RC; Burchardt C; Einsiedel J; Hübner H; Gmeiner P
    J Mol Model; 2019 Jun; 25(7):193. PubMed ID: 31209646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NTS1 and NTS2 mediate analgesia following neurotensin analog treatment in a mouse model for visceral pain.
    Smith KE; Boules M; Williams K; Richelson E
    Behav Brain Res; 2012 Jun; 232(1):93-7. PubMed ID: 22504145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotensin modulates the electrical activity of frog pituitary melanotropes via activation of a G-protein-coupled receptor pharmacologically related to both the NTS1 and nts2 receptors of mammals.
    Belmeguenai A; Vaudry H; Leprince J; Vivet B; Cavelier F; Martinez J; Louiset E
    Neuroendocrinology; 2000 Dec; 72(6):379-91. PubMed ID: 11146421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opening the amino acid toolbox for peptide-based NTS2-selective ligands as promising lead compounds for pain management.
    Previti S; Desgagné M; Tourwé D; Cavelier F; Sarret P; Ballet S
    J Pept Sci; 2023 Jun; 29(6):e3471. PubMed ID: 36539999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel stable analogues of the neurotensin C-terminal hexapeptide containing unnatural amino acids.
    Magafa V; Matsoukas MT; Karageorgos V; Dermitzaki E; Exarchakou R; Stylos EΚ; Pardalos M; Margioris AN; Varvounis G; Tzakos AG; Spyroulias GA; Liapakis G
    Amino Acids; 2019 Jul; 51(7):1009-1022. PubMed ID: 31079216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic and pharmacokinetic profiles of a neurotensin receptor type 2 (NTS2) analgesic macrocyclic analog.
    Chartier M; Desgagné M; Sousbie M; Rumsby C; Chevillard L; Théroux L; Haroune L; Côté J; Longpré JM; Boudreault PL; Marsault É; Sarret P
    Biomed Pharmacother; 2021 Sep; 141():111861. PubMed ID: 34229249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTS2-selective neurotensin mimetics with tetrahydrofuran amino acids.
    Simeth NA; Bause M; Dobmeier M; Kling RC; Lachmann D; Hübner H; Einsiedel J; Gmeiner P; König B
    Bioorg Med Chem; 2017 Jan; 25(1):350-359. PubMed ID: 27842797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors.
    Alshoukr F; Rosant C; Maes V; Abdelhak J; Raguin O; Burg S; Sarda L; Barbet J; Tourwé D; Pelaprat D; Gruaz-Guyon A
    Bioconjug Chem; 2009 Aug; 20(8):1602-10. PubMed ID: 19610615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimized Opioid-Neurotensin Multitarget Peptides: From Design to Structure-Activity Relationship Studies.
    Gonzalez S; Dumitrascuta M; Eiselt E; Louis S; Kunze L; Blasiol A; Vivancos M; Previti S; Dewolf E; Martin C; Tourwé D; Cavelier F; Gendron L; Sarret P; Spetea M; Ballet S
    J Med Chem; 2020 Nov; 63(21):12929-12941. PubMed ID: 32902268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, Structural Optimization, and Characterization of the First Selective Macrocyclic Neurotensin Receptor Type 2 Non-opioid Analgesic.
    Chartier M; Desgagné M; Sousbie M; Côté J; Longpré JM; Marsault E; Sarret P
    J Med Chem; 2021 Feb; 64(4):2110-2124. PubMed ID: 33538583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the proline residue on ligand binding of neurotensin receptor 2 (NTS2)-selective peptide-peptoid hybrids.
    Held C; Hübner H; Kling R; Nagel YA; Wennemers H; Gmeiner P
    ChemMedChem; 2013 May; 8(5):772-8. PubMed ID: 23532897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a role of NTS2 receptors in the modulation of tonic pain sensitivity.
    Roussy G; Dansereau MA; Baudisson S; Ezzoubaa F; Belleville K; Beaudet N; Martinez J; Richelson E; Sarret P
    Mol Pain; 2009 Jul; 5():38. PubMed ID: 19580660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotensin NTS
    Steele FF; Whitehouse SC; Aday JS; Prus AJ
    Brain Res; 2017 Mar; 1658():31-35. PubMed ID: 28089664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of NTS2 in the development of tolerance to NT69L in mouse models for hypothermia and thermal analgesia.
    Smith KE; Boules M; Williams K; Fauq AH; Richelson E
    Behav Brain Res; 2011 Oct; 224(2):344-9. PubMed ID: 21718721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a metabolically stable neurotensin receptor 2 (NTS2) ligand.
    Held C; Plomer M; Hübner H; Meltretter J; Pischetsrieder M; Gmeiner P
    ChemMedChem; 2013 Jan; 8(1):75-81. PubMed ID: 23097347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensorimotor gating in NTS1 and NTS2 null mice: effects of d-amphetamine, dizocilpine, clozapine and NT69L.
    Oliveros A; Heckman MG; Del Pilar Corena-McLeod M; Williams K; Boules M; Richelson E
    J Exp Biol; 2010 Dec; 213(Pt 24):4232-9. PubMed ID: 21113004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of amphetamine on extracellular concentrations of amino acids in striatum in neurotensin subtype 1 and 2 receptor null mice: a possible interaction between neurotensin receptors and amino acid systems for study of schizophrenia.
    Li Z; Liang Y; Boules M; Gordillo A; Richelson E
    Neuropharmacology; 2010 Jun; 58(7):1174-8. PubMed ID: 20193696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.